Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haoliang Zhao

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Diagnostic Pathology|December 14, 2020
Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathwayXiaomin Li, Jiefeng He, Xiaojing Ren, et al.
Frontiers in Bioscience (Landmark Edition)|February 29, 2024
Tumor-Educated Platelet RNA and Circulating Free RNA: Emerging Liquid Biopsy Markers for Different Tumor TypesHaiyang Hu, Huangqin Song, Bin Han, et al.
Oncology Reports|July 8, 2015
Knockdown of SOX18 inhibits the proliferation, migration and invasion of hepatocellular carcinoma cellsGuiming Wang, Zhigang Wei, Hongyan Jia, et al.
Frontiers in Genetics|October 28, 2022
Advances in single-cell sequencing technology in the field of hepatocellular carcinomaRongyi Qin, Haichao Zhao, Qizu He, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|September 13, 2022
Oral Endothelium Corneum Gigeriae Galli Therapy for Pancreatic Duct Stones: A Prospective Cohort StudyDujuan Cao, Huiyu Li, Jinxi Wang, et al.
Annals of Medicine|July 13, 2025
Comparison of the burden of musculoskeletal disorders between China and worldwide data using the global burden of disease dataset from 1990 to 2021Zhongbiao Nie, Ran Zhang, Yaoyao Guo, et al.
Pathology, Research and Practice|February 26, 2022
Prefoldin and prefoldin-like complex subunits as predictive biomarkers for hepatocellular carcinoma immunotherapyHaichao Zhao, Changzhou Chen, Chuanli Yang, et al.
Technology in Cancer Research & Treatment|June 30, 2021
A Prognostic Model for Patients With Gastric Signet Ring Cell CarcinomaQinping Guo, Yinquan Wang, Jie An, et al.
Oncology Letters|March 20, 2018
γδ T cell-mediated individualized immunotherapy for hepatocellular carcinoma considering clinicopathological characteristics and immunosuppressive factorsWei Tian, Jun Ma, Ruyi Shi, et al.
Oncology Letters|January 4, 2020
The HPA/SDC1 axis promotes invasion and metastasis of pancreatic cancer cells by activating EMT via FGF2 upregulationXidong Chen, Haichao Zhao, Changzhou Chen, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Diagnostic Pathology|December 14, 2020
Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathwayXiaomin Li, Jiefeng He, Xiaojing Ren, et al.
Frontiers in Bioscience (Landmark Edition)|February 29, 2024
Tumor-Educated Platelet RNA and Circulating Free RNA: Emerging Liquid Biopsy Markers for Different Tumor TypesHaiyang Hu, Huangqin Song, Bin Han, et al.
Oncology Reports|July 8, 2015
Knockdown of SOX18 inhibits the proliferation, migration and invasion of hepatocellular carcinoma cellsGuiming Wang, Zhigang Wei, Hongyan Jia, et al.
Frontiers in Genetics|October 28, 2022
Advances in single-cell sequencing technology in the field of hepatocellular carcinomaRongyi Qin, Haichao Zhao, Qizu He, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|September 13, 2022
Oral Endothelium Corneum Gigeriae Galli Therapy for Pancreatic Duct Stones: A Prospective Cohort StudyDujuan Cao, Huiyu Li, Jinxi Wang, et al.
Annals of Medicine|July 13, 2025
Comparison of the burden of musculoskeletal disorders between China and worldwide data using the global burden of disease dataset from 1990 to 2021Zhongbiao Nie, Ran Zhang, Yaoyao Guo, et al.
Pathology, Research and Practice|February 26, 2022
Prefoldin and prefoldin-like complex subunits as predictive biomarkers for hepatocellular carcinoma immunotherapyHaichao Zhao, Changzhou Chen, Chuanli Yang, et al.
Technology in Cancer Research & Treatment|June 30, 2021
A Prognostic Model for Patients With Gastric Signet Ring Cell CarcinomaQinping Guo, Yinquan Wang, Jie An, et al.
Oncology Letters|March 20, 2018
γδ T cell-mediated individualized immunotherapy for hepatocellular carcinoma considering clinicopathological characteristics and immunosuppressive factorsWei Tian, Jun Ma, Ruyi Shi, et al.
Oncology Letters|January 4, 2020
The HPA/SDC1 axis promotes invasion and metastasis of pancreatic cancer cells by activating EMT via FGF2 upregulationXidong Chen, Haichao Zhao, Changzhou Chen, et al.
Pageof 4